The metabolic syndrome in cancer survivors

The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.

The summary can be viewed online at http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(09)70287-6/abstract
The full article is availabe for members or at a library which carries issues of the Lancet in Volume 11, Issue 2 pgs.193-203. February 2010.